Atlas Trials

Effect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation.

Clinical trial NCT01669421 · COMPLETED

Trial details

NCT number
NCT01669421
Sponsor
Michael Campos, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alpha 1 Antitrypsin Deficiency
Start date
2012-07-01
Primary completion
2016-05-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.